Cargando…

C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice

Natural IgM antibodies (NAbs) have been shown to recognize injury-associated neoepitopes and to initiate pathogenic complement activation. The NAb termed C2 binds to a subset of phospholipids displayed on injured cells, and its role(s) in arthritis, as well as the potential therapeutic benefit of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banda, Nirmal K., Tomlinson, Stephen, Scheinman, Robert I., Ho, Nhu, Ramirez, Joseline Ramos, Mehta, Gaurav, Wang, Guankui, Vu, Vivian Pham, Simberg, Dmitri, Kulik, Liudmila, Holers, V. Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596757/ https://www.ncbi.nlm.nih.gov/pubmed/33178202 http://dx.doi.org/10.3389/fimmu.2020.575154

Ejemplares similares

In Vitro and In Vivo Differences in Murine Third Complement Component (C3) Opsonization and Macrophage/Leukocyte Responses to Antibody-Functionalized Iron Oxide Nanoworms
por: Wang, Guankui, et al.
Publicado: (2017)

Activation of Human Complement System by Dextran-Coated Iron Oxide Nanoparticles Is Not Affected by Dextran/Fe Ratio, Hydroxyl Modifications, and Crosslinking
por: Wang, Guankui, et al.
Publicado: (2016)

Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement
por: Narang, Aarti, et al.
Publicado: (2017)

Transgenic Mice Overexpressing the Complement Inhibitor Crry as a Soluble Protein Are Protected from Antibody-induced Glomerular Injury
por: Quigg, Richard J., et al.
Publicado: (1998)

Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum
por: Banda, Nirmal K, et al.
Publicado: (2014)

Structures of the rat complement regulator CrrY
por: Roversi, Pietro, et al.
Publicado: (2011)

Key Components of the Complement Lectin Pathway Are Not Only Required for the Development of Inflammatory Arthritis but Also Regulate the Transcription of Factor D
por: Holers, V. Michael, et al.
Publicado: (2020)

IgM exacerbates glomerular disease progression in complement induced glomerulopathy
por: Panzer, Sarah E., et al.
Publicado: (2015)

Immunoglobulin deposition on biomolecule corona determines complement opsonisation efficiency of preclinical and clinical nanoparticles
por: Vu, Vivian P., et al.
Publicado: (2019)

Complement in the Initiation and Evolution of Rheumatoid Arthritis
por: Holers, V. Michael, et al.
Publicado: (2018)

Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking
por: Wu, Lin-Ping, et al.
Publicado: (2021)

Complement Component 5 (C5) Deficiency Improves Cognitive Outcome After Traumatic Brain Injury and Enhances Treatment Effects of Complement Inhibitors C1-Inh and CR2-Crry in a Mouse Model
por: Chen, Min, et al.
Publicado: (2023)

Expression of Membrane Complement Regulatory Proteins Crry and CD55 in Normal Rats
por: Kato, Chie, et al.
Publicado: (2013)

Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21)
por: Pappworth, Isabel Y., et al.
Publicado: (2009)

Crry silencing alleviates Alzheimer’s disease injury by regulating neuroinflammatory cytokines and the complement system
por: Zhu, Xi-Chen, et al.
Publicado: (2022)

A Potential New Mouse Model of Axial Spondyloarthritis Involving the Complement System
por: Holers, V. Michael, et al.
Publicado: (2021)

Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
por: Holers, V. Michael, et al.
Publicado: (2002)

Complement activation is required for IgM-mediated enhancement of the antibody response
Publicado: (1988)

Complement inhibitor Crry expression in mouse placenta is essential for maintaining normal blood pressure and fetal growth
por: Banadakoppa, Manu, et al.
Publicado: (2020)

Complement regulatory protein Crry deficiency contributes to the antigen specific recall response in experimental autoimmune myasthenia gravis
por: Soltys, Jindrich, et al.
Publicado: (2012)

Surface Modification of Erythrocytes with Lipid Anchors: Structure–Activity Relationship for Optimal Membrane Incorporation, in vivo Retention, and Immunocompatibility
por: Gaikwad, Hanmant, et al.
Publicado: (2022)

HETEROGENEITY OF RABBIT IGM ANTIBODY AS DETECTED BY C'1a FIXATION
por: Hoyer, Leon W., et al.
Publicado: (1968)

Three different pathways of IgM-antibody-dependent hemolysis are mainly regulated by complement
por: Bartolmäs, Thilo, et al.
Publicado: (2023)

Dapagliflozin Ameliorates Diabetic Kidney Disease via Upregulating Crry and Alleviating Complement Over-activation in db/db Mice
por: Chang, Dong-Yuan, et al.
Publicado: (2021)

Insights into IgM-mediated complement activation based on in situ structures of IgM-C1-C4b
por: Sharp, Thomas H., et al.
Publicado: (2019)

Prevention of experimental autoimmune myasthenia gravis by rat Crry-Ig: A model agent for long-term complement inhibition in vivo
por: Hepburn, Natalie J., et al.
Publicado: (2008)

Antiphospholipid antibodies harness innate effectors, neutrophils and an alternative pathway of complement, to induce fetal damage
por: Salmon, J, et al.
Publicado: (2003)

The effect of complement on the ingestion of soluble antigen-antibody complexes and IgM aggregates by mouse peritoneal macrophages
Publicado: (1978)

Complement Receptors 1 and 2 in Murine Antibody Responses to IgM-Complexed and Uncomplexed Sheep Erythrocytes
por: Rutemark, Christian, et al.
Publicado: (2012)

Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1
Publicado: (1992)

Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein
Publicado: (1995)

Nanometer- and angstrom-scale characteristics that modulate complement responses to nanoparticles
por: Moghimi, S. Moein, et al.
Publicado: (2022)

THE SUBUNITS IN RABBIT ANTI-FORSSMAN IGM ANTIBODY
por: Frank, Michael M., et al.
Publicado: (1968)

Protective Roles of Natural IgM Antibodies
por: Grönwall, Caroline, et al.
Publicado: (2012)

Complement C4d-specific antibodies for the diagnosis of lung cancer
por: Ajona, Daniel, et al.
Publicado: (2017)

Bead Arrays for Antibody and Complement Profiling Reveal Joint Contribution of Antibody Isotypes to C3 Deposition
por: Ayoglu, Burcu, et al.
Publicado: (2014)

Complement and autoimmunity: new insights into old questions
por: Holers, VM, et al.
Publicado: (2004)

Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5
por: Latuszek, Adrianna, et al.
Publicado: (2020)

Expression dynamics of Crry at the implantation sites in normal pregnancy and response against miscarriage induction
por: KUNIYOSHI, Nobue, et al.
Publicado: (2022)

Foot-and-mouth disease virus localisation on follicular dendritic cells and sustained induction of neutralising antibodies is dependent on binding to complement receptors (CR2/CR1)
por: Gordon, Lucy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b5dn2vh1e8iae4bfeatf7d0gsk